MILESTONE PHARMACEUTICALS
Live / Registered — Registered (as of 02 May 2023)
What this means for you
Registered since 02 May 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88524189
- Registration number
- 7039322
- Mark type
- Stylized text
- Filed
- 19 Jul 2019
- Published for opposition
- 14 Feb 2023
- Registered
- 02 May 2023
- Attorney of record
- Devon E. White
Goods and services
- Class 035 — Advertising and business services: Promoting collaboration within the scientific, research and medical communities to achieve advances in the field of cardiovascular disorders; Promoting the exchange of information and resources within the scientific research and medical communities to achieve advances in the field of cardiovascular disorders
- Class 042 — Scientific and technological services: Providing medical and scientific research information in the field of heart disease and clinical trials; providing medical and scientific research information in the field of cardiovascular disorders and clinical trials; pharmaceutical research services in the field of heart disease and cardiovascular system; pharmaceutical drug development services in the field of heart disease and cardiovascular system; pharmaceutical research and development in the field of heart disease and cardiovascular system; medical and scientific research, namely, conducting clinical trials for others in the field of heart disease and cardiovascular system; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
- Class 044 — Medical, beauty and agricultural services: Providing a resource website featuring information in the field of the treatment of episodic cardiovascular conditions; providing a resource website featuring information for people living with atrial fibrillation/atrial flutter; providing a resource website featuring information for people living with myocardial ischemia including angina; providing a resource website featuring information for people living with supraventricular tachycardias including paroxysmal
Owner
- Milestone Pharmaceuticals USA, Inc., Charlotte, NC, US
- Milestone Pharmaceuticals USA, Inc., Charlotte, NC, US
- Milestone Pharmaceuticals USA, Inc., Charlotte, NC, US
Prosecution history
- 12 Jul 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 12 Jul 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 12 Jul 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 02 May 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 02 May 2023 — REGISTERED-PRINCIPAL REGISTER
- 14 Feb 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Feb 2023 — PUBLISHED FOR OPPOSITION
- 25 Jan 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Jan 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 31 Dec 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 31 Dec 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 31 Dec 2022 — ASSIGNED TO LIE
- 04 Nov 2022 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 08 May 2022 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 08 May 2022 — FINAL REFUSAL E-MAILED